1. Home
  2. OCFC vs DMRA Comparison

OCFC vs DMRA Comparison

Compare OCFC & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$19.67

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$28.71

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCFC
DMRA
Founded
1902
2011
Country
United States
United States
Employees
954
7
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OCFC
DMRA
Price
$19.67
$28.71
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$21.67
$43.00
AVG Volume (30 Days)
829.2K
466.5K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
4.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$47.51
N/A
Revenue Next Year
$21.97
N/A
P/E Ratio
$16.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$16.50
52 Week High
$20.61
$34.89

Technical Indicators

Market Signals
Indicator
OCFC
DMRA
Relative Strength Index (RSI) 51.37 51.33
Support Level $18.89 $22.71
Resistance Level $20.05 $34.89
Average True Range (ATR) 0.42 2.13
MACD -0.06 -0.44
Stochastic Oscillator 32.43 9.51

Price Performance

Historical Comparison
OCFC
DMRA

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: